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The Importance of a Full Clinical Examination: Assessment of
Index Lesions Referred to a Skin Cancer Clinic Without a Total
Body Skin Examination Would Miss One in Three Melanomas
Roger B. ALDRIDGE, Lisa NAYSMITH, Ee Ting OOI, Caroline S. MURRAY, and Jonathan L.
REES
Department of Dermatology, University of Edinburgh, Edinburgh, United Kingdom
Abstract
Traditional clinical teaching emphasises the importance of a full clinical examination. In the
clinical assessment of lesions that may be skin cancer, full examination allows detection of
incidental lesions, as well as helping in the characterisation of the index lesion. Despite this, a total
body skin examination is not always performed. Based on two prospective studies of over 1,800
sequential patients in two UK centres we show that over one third of melanomas detected in
secondary care are found as incidental lesions, in patients referred for assessment of other
potential skin cancers. The majority of these melanomas occurred in patients whose index lesion
turned out to be benign. Alternative models of care – for instance some models of teledermatology
in which a total body skin examination is not performed by a competent practitioner – cannot be
considered equivalent to a traditional consultation and, if adopted uncritically, without system
change, will likely lead to melanomas being missed.
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Traditional clinical teaching emphasises the importance of a full clinical examination for
accurate patient assessment and management. In the assessment of index lesions that may be
skin cancer there are several cogent arguments for examining the whole of the patient’s skin
(i.e. a total body skin examinations (TBSE)). First, the incidence rate of skin cancer is so
high that patients may present with more than one cancer at a single time point, but be
unaware of the non-index lesion (if, for instance it is on a body-site that is hard to observe,
such as the mid-back). Second, the diagnostic process for any particular lesion should be
influenced by factors beyond the index lesion. Perhaps the clearest example of this would be
the use of the ‘Ugly Duckling’ sign, in which the assessment of an individual pigmented
lesion is heavily influenced by the morphology of other non-index pigmented lesions (1, 2).
Although we know of no systematic data on this topic, some of the authors have been
increasingly aware of a tendency for clinicians – both in primary and secondary care – to fail
to fully undress patients who present with index lesions for which skin cancer is a possible
diagnosis. The reasons for this change are unclear, but may relate to time pressures in
clinical practice, changing norms about patient consent, and scepticism about the rate and
importance of searching for incidental lesions and hence the value of a TBSE. This topic has
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a particular timeliness given attempts to replace conventional clinical examination with
teledermatology. There are various proposed models of teledermatology, involving different
degrees of investigation of an individual patient. In some instances, clinical
recommendations are made based on a photograph of an index lesion without assessment of
the rest of the patient’s skin by a certified physician (3, 4).
The present study is an attempt to produce estimates for the magnitude of the following
problem: what proportion of melanomas would we expect to miss if physicians only
examine the index lesion, rather than conducting a TBSE? We describe two prospective
studies, performed in two separate UK dermatology departments; one is a district general
hospital, the other a central teaching hospital. We prospectively recorded on a consecutive
series of patients the numbers of index melanomas (based on the referred index lesion) and
incidental melanomas (based on the results of the TBSE) in patients referred to two skin
lesion cancer clinics.
METHODS
Study 1
The numbers of incidental melanomas were determined in a cohort of patients referred by
primary care physicians for dermatological assessment of index lesions suspicious for any
type of skin cancer (i.e. non-melanoma skin cancer and melanoma). The study was
undertaken prospectively at a district general hospital that serves a defined geographic
population in the West of Scotland (Stobhill Hospital, Glasgow). In this hospital the
Dermatology department runs a weekly half-day skin lesion clinic, alternating between
Tuesdays and Fridays, to which all referrals for the diagnosis of any type of skin cancer are
assigned. All patients who attended the Friday fortnightly skin lesion clinic over a 9-month
period between January and october 2010 were asked to participate as part of a larger
research study involving photography of skin tumours. All participants had their index
lesion recorded and photographed, along with any incidental lesions that were deemed by a
consultant dermatologist to merit a biopsy. These incidental lesions were identified during a
TBSE, which was routinely offered to all patients at the time of index lesion evaluation.
Study 2
In the second study, melanoma diagnoses were investigated in a hospital with a different
geographical location that served a larger population. This study was undertaken
prospectively at the Edinburgh Royal Infirmary, Edinburgh, a central University teaching
hospital in the South-east of Scotland. In this centre the Dermatology department runs twice
weekly full-day lesion clinics, again on Tuesdays and Fridays, to which all lesion referrals
from primary care are sequentially assigned. All patients who attended the Friday weekly
skin lesion clinic over a 6-month period between July and December 2011 were enrolled.
In Study 2 (but not Study 1) the full demographics of the total referred patient population
were recorded, along with the details of all index and incidental melanomas identified
during the study period. Coupled with cancer registry data produced by the Information
Services Division (ISD) (5) for the same area (South-East Scotland), we were able to
estimate how many melanomas we might have expected to see within our referred
population.
Ethics and statistics
NHS Lothian research ethics committee granted permission for the study and NHS Greater
Glasgow and Clyde research and development approved the site extension for Stobhill
Hospital.
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All data was entered into a spreadsheet and then exported into ‘R’ for graphing and
statistical analysis (6).
RESULTS
Study 1
Three-hundred and thirty-six patients met the inclusion criteria and agreed to participate.
The mean age was 54 years (range 16-95), and 60% were female (203/336). This represents
an enrolment rate of 87% (336/386) of the total eligible patients who attended the clinics
over this period. Patients under the age of 16 (n = 7) or with a lesion on a sensitive body site
(n = 9) were ineligible due to ethical approval constraints surrounding the photography of
lesions (Study 1 was nested within a larger research study requiring photography of
individual lesions – this photographic study is not germane to the present findings). These
patients and the other patients (n = 34) who did not wish to be photographed all had benign
index lesions and no incidental malignancies.
Twenty-three additional incidental lesions were biopsied. The diagnoses and distribution of
all the index lesions referred (n = 336) and incidental lesions biopsied (n = 23) are
summarised in Table I. The majority of the index lesions referred were not malignant (85%,
287/336), although a further 15% (51/336) of these referrals were for what might be termed
“pre-malignant” or “dysplastic” conditions (intra-epithelial carcinomas, actinic keratoses,
dysplastic naevi and keratoacanthomas).
In total, 9 melanomas were diagnosed in the study cohort. Four of these melanomas were
index lesions, giving a pick up rate of 1.2% (4/336) of referred index lesions. None of these
index melanomas were melanoma in situ (MIS), and their mean Breslow depth was 0.42
mm. Five incidental melanomas were identified during TBSEs of the study cohort, equating
to a pick up rate of 1.5% (5/336). Three of these incidental melanomas were MIS, and the
mean Breslow depth of the (invasive) melanomas was 0.32 mm. Therefore the index to
incidental melanoma ratio was 4:5, with 56% of the melanomas in the study cohort detected
incidentally. In all 5 of these incidental melanomas the index lesion had been benign (see
Table II).
Study 2
One-thousand five-hundred and fifteen patients attended the skin lesion clinics over the 6-
month period. The mean age was 57 years (range 3–99) and 60% (912/1,515) were female.
The study population, sorted by age and sex, is graphically presented in Fig. S1 (available
from http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-1625).
In total, 29 melanomas were diagnosed in the referred population. Twenty of these
melanomas were index lesions, giving an index melanoma rate of 1.3% (20/1,515) of
referred lesions. Thirty percent (6/20) of these index melanomas were MIS, and the mean
Breslow depth of the (invasive) melanomas was 1.03 mm. Nine incidental melanomas were
identified by TBSE in the referred patients, with a pick-up rate of 0.6% (9/1,515) of patients
referred. Again, a third (3/9) of these incidental melanomas were MIS, and the mean
Breslow depth of the (invasive) melanomas was 0.47 mm. The index to incidental melanoma
ratio was 20:9, with 31% of melanomas diagnosed as incidental lesions. In the majority (5/9)
of these incidental melanomas the index lesion was not malignant (see Table III).
Based on age- and sex-standardised melanoma incidence rates for South East Scotland
(Information Services Division, ISD, NHS Scotland) (5) this group of patients – if they were
members of the general population rather than high risk skin cancer patients – would have
been expected to develop 0.58 invasive melanomas over a 12-month period. The count of
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incidental lesions seen was however almost ten times higher, with six invasive melanomas
detected.
DISCUSSION
The data clearly show that a substantial proportion of the melanomas detected at our skin
lesion clinics are incidental findings discovered because we perform a TBSE, in addition to
examination of the referred index lesion. Such diagnoses make a significant contribution to
total melanoma numbers. Single index lesion assessment resulted in a melanoma pick up
rate of 1.3% (24/1851) compared to 2.1% (38/1,851) for the assessment incorporating a total
body skin examination, due to an incidental melanoma rate of 0.8% (14/1,851). Failure to
perform a TBSE would lead to over one third of melanomas being missed.
With a total of 1,851 patients consecutively recruited, these two studies are the largest
cohort(s) published that prospectively investigated the rate of incidental melanomas in
patients referred to skin lesion clinics. Furthermore, despite the obvious geographical and
demographic differences between our two UK studies and those previously published (see
Table IV), the ratios of incidental to index melanomas at 5:4 and 9:20 are within those found
for what might be considered ‘high risk’ populations (7-9).
In keeping with previous UK studies most of the patients referred to our lesion clinics did
not have malignant lesions (10). In addition, the majority of those with incidental
melanomas were referred with lesions that turned out to be benign. If teledermatology of
index lesions alone – without a TBSE performed by a dermatologist – had been employed
these patients might have been returned to primary care without further examination, and
presumably without detection of the melanomas. We do not know if the referring physicians
failed to identify these incidental melanomas because they did not perform a TBSE, or
because the incidental melanomas were misdiagnosed as benign. We note, however, that 4
of the 14 incidental melanomas identified were likely to have been in the referring
physician’s field of view at the time of initial index lesion examination (see Tables II & III –
melanoma numbers 3, 4, 12 & 13). The fact that many of the incidental melanomas were
located alongside benign index lesions suggests that the referring physicians did not possess
the necessary skills required to consistently choose the single most relevant index lesion to
submit for expert assessment.
The value of routinely including a TBSE within general dermatology consultations, even
when the patient’s presenting complaint does not specifically require such a complete full
body examination, has been reported previously, with incidental melanoma pick up rates of
0.3% (11) and 0.6% (12). The crucial differences between these studies and the two
presented in this manuscript are that our studies were exclusively on patients referred
because of concern about skin cancer, and because we specifically examined the differences
in melanoma pick up rates between single lesion assessment and TBSE. Although the
apparent higher rate of incidental melanomas in our cohort(s) might only be due to
demographic differences between the patient populations, it is also to be expected that
patients referred with suspicious index skin lesions have a higher rate of incidental
melanomas than the general dermatological patient population.
The incidental melanomas we detected based on TBSE would have most probably been
detected at a later stage, perhaps when patients themselves noted them. Although we do not
know when this might have been, given the importance attached to early diagnosis in
melanoma, as a group, the patients’ prognosis would have been adversely affected. In the
present studies the Breslow thickness of the incidental melanomas was lower (but not
formally statistically significantly so) in those melanomas detected as incidental lesions
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(mean 0.42 mm vs. 0.93 mm, t-test p = 0.08). Such findings are in keeping with previous
work that has demonstrated thinner Breslow depths in those patients diagnosed with
melanoma who have undergone recent TBSE (13).
There is one other finding that is worth commenting on because it is germane to issues about
performing total skin examinations and screening, or searching out melanomas in those who
do not present to their medical practitioner with a suspicious pigmented lesion as the
principal complaint.
In Study 2, we used age and sex data to make a very rough estimate of how many
melanomas we might have expected to find in the patient group we studied. This is not a
straightforward task for a number of reasons. For instance, relating the number of incidental
lesions present at the single point in time when we examined patients, to the rate of
appearance of index lesions over a period of time presenting to medical services, depends on
how long lesions are present on an individual before an individual presents to medical
services. This in turn influences the ‘pool’ of subclinical disease that exists at any one time
in the community, but which is not captured by incidence rates. Furthermore, as highlighted
above, the patient group examined are likely to be at a higher risk for melanoma because
many of them had been referred with other suspected skin cancer lesions, although of course
only a minority turned out to have skin cancer. We cannot take these factors into account by
just age and sex standardisation, but feel our results may inform the work of others. The
finding of 6 incidental invasive melanomas at a particular time point against an expected
total melanoma count of 0.6 over a one-year period in the patients we examined is a tenfold
difference. We suggest that this large difference is surely in keeping with the idea that there
is a significant pool of lesions that are present in the community that clinically and
pathologically are identical to other index lesions that are diagnosed as melanoma, although
whether all these lesions would progress to metastatic disease is unclear (14).
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Table I
The diagnoses and distributions of all referred index lesions (n = 336) and all biopsied
incidental lesions (n = 23) from Study One
Index lesions
n (%)
Incidental lesions
n (%)
Diagnosis
 Actinic keratosis 18(5.4)
 Angiosarcoma 1 (0.3)
 Adenexal tumour – benign 5 (1.5) 1 (4.3)
 Basal cell carcinoma 36 (10.7) 7 (30.4)
 Chondrodermatitis nodular helicis 5 (1.5)
 Cysts – benign 4 (1.2)
 Dermatofibroma 7 (2.1)
 Haemangioma 6 (1.8)
 Intra-epithelial carcinoma 21 (6.2) 4 (17.4)
 Keratoacanthoma 1 (0.3)
 Lentigo 16 (4.8)
 Lichenoid keratosis 6 (1.8)
 Melanocytic naevus – benign 85 (25.3)
 Melanocytic naevus – dysplastic 11 (3.3) 6 (26.1)
 Melanoma/Melanoma in situ 4 (1.2) 5 (21.7)
 Pyogenic granuloma 5 (1.5)
 Seborrheic keratosis 69 (20.5)
 Squamous cell carcinoma 8 (2.4)
 Viral Wart 9 (2.7)
 Other (dermatoses – not lesions) 19 (5.7)
Distribution
 Lip 5 (1.5)
 Ear 12 (3.6)
 Nose 18 (5.4) 2 (8.7)
 Face 70 (20.8) 5 (21.7)
 Scalp 16 (4.8)
 Neck 9 (2.7)
 Trunk 50 (14.9) 2 (8.7)
 Back 73 (21.7) 7 (30.4)
 Upper limb 35 (10.4)
 Lower limb 48 (14.3) 7 (30.4)
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Table II
The characteristics of the 5 incidental melanomas identified during Study 1, along with
the details of their final clinical diagnosis of the corresponding referred index lesion
Incidental melanomas Referred index lesion
No. Breslow depth Site Diagnosis Site
1 Melanoma in situ Leg Dermatitis Torso
2 Melanoma in situ Back Haemangioma Face
3 Melanoma in situ Back Seborrheic keratosis Back
4 0.3 mm Back Seborrheic keratosis Back
5 1.3 mm Leg Seborrheic keratosis Back
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Table III
The characteristics of the 9 incidental melanomas identified during study Study 2, along
with the details of the final clinical diagnosis corresponding the referred index lesion
Incidental melanomas Referred index lesion
No. Breslow depth Site Diagnosis Site
6 Melanoma in situ Arm Actinic keratosis Face
7 Melanoma in situ Neck Seborrheic keratosis Back
8 Melanoma in situ Arm Cyst Back
9 0.24 mm Arm Chondrodermatitis nodular helices Ear
10 0.43 mm Back Basal cell carcinoma Cheek
11 0.5 mm Arm Squamous cell carcinoma Scalp
12 0.66 mm Back Basal cell carcinoma Back
13 0.8 mm Leg Melanocytic naevus Leg
14 1.6 mm Back Melanoma in situ Cheek
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Table IV
Details of the three studies identified in the literature where comparisons were made
between the rates of ‘incidental’ and ‘index’ melanomas. Also included in the table are
the details of the two studies described in this manuscript
Study design Location Population
Index:Incidental
melanoma ratio
Incidental
melanomas (%)
Prospective cohort Glasgow, UK (Study One) 336 skin lesion patients 4:5 56
Prospective cohort Edinburgh, UK (Study Two) 1,515 skin lesion patients 20:9 31
Retrospective cohort Connecticut, USA (9) 400 skin lesion patients 5:6 55
Retrospective case series Perth, Australia (7) 94 melanoma patients 37:57 61
Retrospective case series Florida, USA (8) 126 melanoma patients 55:71 56
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